Cargando…
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression
Apart from indolent systemic mastocytosis (SM), which is associated with a favorable prognosis, other subtypes of SM (SM with associated clonal hematologic non–mast cell lineage disease, aggressive SM, and mast cell leukemia – collectively referred to in this review as advanced SM) can be debilitati...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761194/ https://www.ncbi.nlm.nih.gov/pubmed/23181448 http://dx.doi.org/10.1111/ejh.12043 |